Curcumin Protects Against Collagen-induced Arthritis Via Suppression of BAFF Production

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2012 Nov 28

PMID 23184090

Citations 27

Authors

Gang Huang

Zhizhen Xu

Yan Huang

Xiaojun Duan

Wei Gong

Yan Zhang

Jishan Fan

Fengtian He

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of the present study was to evaluate whether the anti-Rheumatoid arthritis (RA) effect of curcumin is associated with the regulation of B cell-activating factor belonging to the TNF family (BAFF) production.

Methods: Collagen-induced arthritis (CIA) was induced in DBA/1 J mice by immunization with bovine type II collagen. To investigate the anti-arthritic effect of curcumin in the CIA model, mice were injected intraperitoneally with curcumin (50 mg/kg) on every other day either from day 1 or from day 28 after the first immunization. The clinical severity of arthritis was monitored. BAFF, interleukin-6 (IL-6) and interferon-γ (IFNγ) production in serum were measured. Furthermore, the effect of curcumin on IFNγ-induced BAFF expression and transcriptional activation in B lymphocytes was determined by qPCR, Western Blot, and luciferase assay. Finally, IFNγ related signal transducers and activators of transcription 1 (STAT1) signaling in B lymphocytes were studied using Western Blot.

Results: Curcumin dramatically attenuated the progression and severity of CIA in DBA/1 J mice, accompanied with decrease of BAFF production in serum and spleen cells as well as decrease of serum IFNγ and IL-6. Treatment of B lymphocytes with curcumin suppressed IFNγ-induced BAFF expression, STAT1 phosphorylation and nuclear translocation, suggesting that curcumin may repress IFNγ-induced BAFF expression via negatively interfering with STAT1 signaling.

Conclusion: The results of the present study suggest that suppression of BAFF production may be a novel mechanism by which curcumin improves RA.

Citing Articles

Rheumatoid arthritis-recent advances in pathogenesis and the anti-inflammatory effect of plant-derived COX inhibitors.

Bashir U, Singh G, Bhatia A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5363-5385.

PMID: 38358467 DOI: 10.1007/s00210-024-02982-3.

A quinazoline derivative suppresses B cell hyper-activation and ameliorates the severity of systemic lupus erythematosus in mice.

Zhang G, Yang F, Li J, Chen S, Kong Y, Mo C Front Pharmacol. 2023; 14:1159075.

PMID: 37256224 PMC: 10225574. DOI: 10.3389/fphar.2023.1159075.

Pharmacological Mechanisms and Clinical Applications of Curcumin: Update.

Hao M, Chu Y, Lei J, Yao Z, Wang P, Chen Z Aging Dis. 2023; 14(3):716-749.

PMID: 37191432 PMC: 10187702. DOI: 10.14336/AD.2022.1101.

Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis.

Kuboi Y, Suzuki Y, Motoi S, Matsui C, Toritsuka N, Nakatani T Mol Ther Nucleic Acids. 2023; 31:339-351.

PMID: 36789273 PMC: 9900455. DOI: 10.1016/j.omtn.2023.01.005.

The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation.

Moudgil K, Venkatesha S Int J Mol Sci. 2023; 24(1).

PMID: 36613560 PMC: 9820125. DOI: 10.3390/ijms24010095.

References

Ji J, Huang X, Zhu H . Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem. 2011; 12(3):210-8. DOI: 10.2174/187152012800228733. View

Ohata J, Zvaifler N, Nishio M, Boyle D, Kalled S, Carson D . Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol. 2005; 174(2):864-70. DOI: 10.4049/jimmunol.174.2.864. View

McInnes I, Schett G . The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23):2205-19. DOI: 10.1056/NEJMra1004965. View

Gheita T, Bassyouni I, Emad Y, Nour El-Din A, Abdel-Rasheed E, Hussein H . Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity. Joint Bone Spine. 2011; 79(3):285-90. DOI: 10.1016/j.jbspin.2011.05.020. View

de la Torre I, Moura R, Leandro M, Edwards J, Cambridge G . B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy. Ann Rheum Dis. 2010; 69(12):2181-8. DOI: 10.1136/ard.2010.131326. View

Kim H, Jeon S, Seo G, Park J, Kim P . TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. J Leukoc Biol. 2008; 83(6):1431-9. DOI: 10.1189/jlb.1007676. View

Park S, Jung M, Jeon S, Park M, Park K, Lee M . IFN-gamma down-regulates TGF-beta1-induced IgA expression through Stat1 and p300 signaling. Mol Cells. 2009; 29(1):57-62. DOI: 10.1007/s10059-010-0004-4. View

Dennis G . Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus. Clin Pharmacol Ther. 2011; 91(1):143-9. DOI: 10.1038/clpt.2011.290. View

Xu Z, Huang G, Gong W, Zhou P, Zhao Y, Zhang Y . FXR ligands protect against hepatocellular inflammation via SOCS3 induction. Cell Signal. 2012; 24(8):1658-64. DOI: 10.1016/j.cellsig.2012.04.015. View

10.

Aggarwal B, Harikumar K . Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2008; 41(1):40-59. PMC: 2637808. DOI: 10.1016/j.biocel.2008.06.010. View

11.

Pers J, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C . BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005; 1050:34-9. DOI: 10.1196/annals.1313.004. View

12.

Liu Z, Davidson A . BAFF inhibition: a new class of drugs for the treatment of autoimmunity. Exp Cell Res. 2011; 317(9):1270-7. PMC: 3092018. DOI: 10.1016/j.yexcr.2011.02.005. View

13.

Hegen M, Keith Jr J, Collins M, Nickerson-Nutter C . Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis. 2007; 67(11):1505-15. DOI: 10.1136/ard.2007.076430. View

14.

Chandran B, Goel A . A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012; 26(11):1719-25. DOI: 10.1002/ptr.4639. View

15.

Zhang M, Ko K, Lam Q, Lo C, Srivastava G, Zheng B . Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol. 2005; 17(8):1081-92. DOI: 10.1093/intimm/dxh287. View

16.

Recio M, Andujar I, Rios J . Anti-inflammatory agents from plants: progress and potential. Curr Med Chem. 2012; 19(14):2088-103. DOI: 10.2174/092986712800229069. View

17.

Lied G, Berstad A . Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol. 2010; 73(1):1-7. DOI: 10.1111/j.1365-3083.2010.02470.x. View

18.

Li P, Liu D, Liu Y, Song S, Wang Q, Chang Y . BAFF/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin. J Ethnopharmacol. 2012; 141(1):290-300. DOI: 10.1016/j.jep.2012.02.034. View

19.

Mun S, Kim H, Kim J, Ko N, Kim D, Lee B . Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci. 2009; 111(1):13-21. DOI: 10.1254/jphs.09134fp. View

20.

Aggarwal B, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G . Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 2007; 73(7):1024-32. DOI: 10.1016/j.bcp.2006.12.010. View